Xinli Gan

Treatment response, survival, and safety profile of camrelizumab plus apatinib regimen as third-line treatment in metastatic gastric cancer patients.

Hui Qiao, Xiaomin Chen, N. Ma, 2022, Clinics and research in hepatology and gastroenterology.

ncRNAs-mediated high expression of TIMM8A correlates with poor prognosis and act as an oncogene in breast cancer

Zhonglin Wang, Feng Xu, Jie Sun, 2021, Cancer cell international.

High expression of ALDOA and DDX5 are associated with poor prognosis in human colorectal cancer

N. Tan, Xiaobao Zhu, Xinli Gan, 2018, Cancer management and research.